Username

Password

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Douglas Richman

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Living Beings

HIV-1
HIV

Disorders

Chemicals & Drugs

Physiology

Concepts & Ideas

Procedures

Anatomy

CD4-Positive T-Lymphocytes

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Butler David M; Pacold Mary E; Jordan Parris S; Richman Douglas D; Smith Davey M
The efficiency of single genome amplification and sequencing is improved by quantitation and use of a bioinformatics tool.
Hightower George K; Letendre Scott L; Cherner Mariana; Gibson Sarah A; Ellis Ronald J; Wolfson Tanya J; Gamst Anthony C; Ignacio Caroline C; Heaton Robert K; Grant Igor; Richman Douglas D; Smith Davey M;
Select resistance-associated mutations in blood are associated with lower CSF viral loads and better neuropsychological performance.
Smith Davey M; May Susanne J; Pérez-Santiago Josué; Strain Matthew C; Ignacio Caroline C; Haubrich Richard H; Richman Douglas D; Benson Constance A; Little Susan J
The use of pooled viral load testing to identify antiretroviral treatment failure.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Douglas Richman (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Butler David M; Pacold Mary E; Jordan Parris S; Richman Douglas D; Smith Davey M
The efficiency of single genome amplification and sequencing is improved by quantitation and use of a bioinformatics tool.
Journal of virological methods 2009;162(1-2):280-3.
2009: Hightower George K; Letendre Scott L; Cherner Mariana; Gibson Sarah A; Ellis Ronald J; Wolfson Tanya J; Gamst Anthony C; Ignacio Caroline C; Heaton Robert K; Grant Igor; Richman Douglas D; Smith Davey M;
Select resistance-associated mutations in blood are associated with lower CSF viral loads and better neuropsychological performance.
Virology 2009;394(2):243-8.
2009: Smith Davey M; May Susanne J; Pérez-Santiago Josué; Strain Matthew C; Ignacio Caroline C; Haubrich Richard H; Richman Douglas D; Benson Constance A; Little Susan J
The use of pooled viral load testing to identify antiretroviral treatment failure.
AIDS (London, England) 2009;23(16):2151-8.
2009: Jordan Parris S; Poon Art; Eron Joseph; Squires Kathleen; Ignacio Caroline; Richman Douglas D; Smith Davey M
A novel codon insert in protease of clade B HIV type 1.
AIDS research and human retroviruses 2009;25(5):547-50.
2009: Richman Douglas D; Margolis David M; Delaney Martin; Greene Warner C; Hazuda Daria; Pomerantz Roger J
The challenge of finding a cure for HIV infection.
Science (New York, N.Y.) 2009;323(5919):1304-7.
2009: Smith Davey M; Zárate Selene; Shao Hai; Pillai Satish K; Letendre Scott L; Wong Joseph K; Richman Douglas D; Frost Simon D W; Ellis Ronald J;
Pleocytosis is associated with disruption of HIV compartmentalization between blood and cerebral spinal fluid viral populations.
Virology 2009;385(1):204-8.
2009: Smith Davey M; May Susanne J; Tweeten Samantha; Drumright Lydia; Pacold Mary E; Kosakovsky Pond Sergei L; Pesano Rick L; Lie Yolanda S; Richman Douglas D; Frost Simon D W; Woelk Christopher H; Little Susan J
A public health model for the molecular surveillance of HIV transmission in San Diego, California.
AIDS (London, England) 2009;23(2):225-32.
2008: Precopio Melissa L; Butterfield Tiffany R; Casazza Joseph P; Little Susan J; Richman Douglas D; Koup Richard A; Roederer Mario
Optimizing peptide matrices for identifying T-cell antigens.
Cytometry. Part A : the journal of the International Society for Analytical Cytology 2008;73(11):1071-8.
2008: Kosakovsky Pond S L; Poon A F Y; Zárate S; Smith D M; Little S J; Pillai S K; Ellis R J; Wong J K; Leigh Brown A J; Richman D D; Frost S D W
Estimating selection pressures on HIV-1 using phylogenetic likelihood models.
Statistics in medicine 2008;27(23):4779-89.
2008: Hirsch Martin S; Günthard Huldrych F; Schapiro Jonathan M; Brun-Vézinet Françoise; Clotet Bonaventura; Hammer Scott M; Johnson Victoria A; Kuritzkes Daniel R; Mellors John W; Pillay Deenan; Yeni Patrick G; Jacobsen Donna M; Richman Douglas D;
Antiretroviral drug resistance testing in adult HIV-1 infection: 2008 recommendations of an International AIDS Society-USA panel.
Topics in HIV medicine : a publication of the International AIDS Society, USA 2008;16(3):266-85.
2008: Hammer Scott M; Eron Joseph J; Reiss Peter; Schooley Robert T; Thompson Melanie A; Walmsley Sharon; Cahn Pedro; Fischl Margaret A; Gatell Jose M; Hirsch Martin S; Jacobsen Donna M; Montaner Julio S G; Richman Douglas D; Yeni Patrick G; Volberding Paul A;
Antiretroviral treatment of adult HIV infection: 2008 recommendations of the International AIDS Society-USA panel.
JAMA : the journal of the American Medical Association 2008;300(5):555-70.
2008: Butler David M; Smith Davey M; Cachay Edward R; Hightower George K; Nugent Charles Thomas; Richman Douglas D; Little Susan J
Herpes simplex virus 2 serostatus and viral loads of HIV-1 in blood and semen as risk factors for HIV transmission among men who have sex with men.
AIDS (London, England) 2008;22(13):1667-71.
2008: Grant Robert M; Hamer Dean; Hope Thomas; Johnston Rowena; Lange Joep; Lederman Michael M; Lieberman Judy; Miller Christopher J; Moore John P; Mosier Donald E; Richman Douglas D; Schooley Robert T; Springer Marty S; Veazey Ronald S; Wainberg Mark A
Whither or wither microbicides?
Science (New York, N.Y.) 2008;321(5888):532-4.
2008: Hirsch Martin S; Günthard Huldrych F; Schapiro Jonathan M; Brun-Vézinet Françoise; Clotet Bonaventura; Hammer Scott M; Johnson Victoria A; Kuritzkes Daniel R; Mellors John W; Pillay Deenan; Yeni Patrick G; Jacobsen Donna M; Richman Douglas D
Antiretroviral drug resistance testing in adult HIV-1 infection: 2008 recommendations of an International AIDS Society-USA panel.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2008;47(2):266-85.
2008: Little Susan J; Frost Simon D W; Wong Joseph K; Smith Davey M; Pond Sergei L Kosakovsky; Ignacio Caroline C; Parkin Neil T; Petropoulos Christos J; Richman Douglas D
Persistence of transmitted drug resistance among subjects with primary human immunodeficiency virus infection.
Journal of virology 2008;82(11):5510-8.
2008: Liu Lin; May Susanne; Richman Douglas D; Hecht Frederick M; Markowitz Martin; Daar Eric S; Routy Jean-Pierre; Margolick Joseph B; Collier Ann C; Woelk Christopher H; Little Susan J; Smith Davey M
Comparison of algorithms that interpret genotypic HIV-1 drug resistance to determine the prevalence of transmitted drug resistance.
AIDS (London, England) 2008;22(7):835-9.
2008: Cachay Edward R; Frost Simon D W; Poon Art F Y; Looney David; Rostami Sherry M; Pacold Mary E; Richman Douglas D; Little Susan J; Smith Davey M
Herpes simplex virus type 2 acquisition during recent HIV infection does not influence plasma HIV levels.
Journal of acquired immune deficiency syndromes (1999) 2008;47(5):592-6.
2008: Johnson Victoria A; Brun-Vezinet Francoise; Clotet Bonaventura; Gunthard Huldrych F; Kuritzkes Daniel R; Pillay Deenan; Schapiro Jonathan M; Richman Douglas D
Update of the Drug Resistance Mutations in HIV-1: Spring 2008.
Topics in HIV medicine : a publication of the International AIDS Society, USA 2008;16(1):62-8.
2008: Koelsch Kersten K; Liu Lin; Haubrich Richard; May Susanne; Havlir Diane; Günthard Huldrych F; Ignacio Caroline C; Campos-Soto Paula; Little Susan J; Shafer Robert; Robbins Gregory K; D'Aquila Richard T; Kawano Yuji; Young Karen; Dao Phillip; Spina Celsa A; Richman Douglas D; Wong Joseph K
Dynamics of total, linear nonintegrated, and integrated HIV-1 DNA in vivo and in vitro.
The Journal of infectious diseases 2008;197(3):411-9.
2007: Poon Art F Y; Kosakovsky Pond Sergei L; Richman Douglas D; Frost Simon D W
Mapping protease inhibitor resistance to human immunodeficiency virus type 1 sequence polymorphisms within patients.
Journal of virology 2007;81(24):13598-607.
2007: Johnson Victoria A; Brun-Vézinet Françoise; Clotet Bonaventura; Günthard Huldrych F; Kuritzkes Daniel R; Pillay Deenan; Schapiro Jonathan M; Richman Douglas D
Update of the drug resistance mutations in HIV-1: 2007.
Topics in HIV medicine : a publication of the International AIDS Society, USA 2007;15(4):119-25.
2007: Smith Davey M; Wong Joseph K; Shao Hai; Hightower George K; Mai Stephanie H T; Moreno Joseph M; Ignacio Caroline C; Frost Simon D W; Richman Douglas D; Little Susan J
Long-term persistence of transmitted HIV drug resistance in male genital tract secretions: implications for secondary transmission.
The Journal of infectious diseases 2007;196(3):356-60.
2007: Woelk Christopher H; Frost Simon D W; Richman Douglas D; Higley Prentice E; Kosakovsky Pond Sergei L
Evolution of the interferon alpha gene family in eutherian mammals.
Gene 2007;397(1-2):38-50.
2007: Cachay Edward R; Frost Simon D W; Richman Douglas D; Smith Davey M; Little Susan J
Herpes simplex virus type 2 infection does not influence viral dynamics during early HIV-1 infection.
The Journal of infectious diseases 2007;195(9):1270-7.
2007: Noviello C M; Pond S L Kosakovsky; Lewis M J; Richman D D; Pillai S K; Yang O O; Little S J; Smith D M; Guatelli J C
Maintenance of Nef-mediated modulation of major histocompatibility complex class I and CD4 after sexual transmission of human immunodeficiency virus type 1.
Journal of virology 2007;81(9):4776-86.
2007: Poon Art F Y; Kosakovsky Pond Sergei L; Bennett Phil; Richman Douglas D; Leigh Brown Andrew J; Frost Simon D W
Adaptation to human populations is revealed by within-host polymorphisms in HIV-1 and hepatitis C virus.
PLoS pathogens 2007;3(3):e45.
2006: Smith Davey M; Strain Matthew C; Frost Simon D W; Pillai Satish K; Wong Joseph K; Wrin Terri; Liu Yang; Petropolous Christos J; Daar Eric S; Little Susan J; Richman Douglas D
Lack of neutralizing antibody response to HIV-1 predisposes to superinfection.
Virology 2006;355(1):1-5.
2006: Day John R; Martínez Laura E; Sásik Roman; Hitchin Douglas L; Dueck Megan E; Richman Douglas D; Guatelli John C
A computer-based, image-analysis method to quantify HIV-1 infection in a single-cycle infectious center assay.
Journal of virological methods 2006;137(1):125-33.
2006: Richman Douglas D
Antiviral drug resistance.
Antiviral research 2006;71(2-3):117-21.
2006: Hammer Scott M; Saag Michael S; Schechter Mauro; Montaner Julio S G; Schooley Robert T; Jacobsen Donna M; Thompson Melanie A; Carpenter Charles C J; Fischl Margaret A; Gazzard Brian G; Gatell Jose M; Hirsch Martin S; Katzenstein David A; Richman Douglas D; Vella Stefano; Yeni Patrick G; Volberding Paul A;
Treatment for adult HIV infection: 2006 recommendations of the International AIDS Society--USA panel.
Topics in HIV medicine : a publication of the International AIDS Society, USA 2006;14(3):827-43.
2006: Johnson Victoria A; Brun-Vezinet Francoise; Clotet Bonaventura; Kuritzkes Daniel R; Pillay Deenan; Schapiro Jonathan M; Richman Douglas D
Update of the drug resistance mutations in HIV-1: Fall 2006.
Topics in HIV medicine : a publication of the International AIDS Society, USA 2006;14(3):125-30.
2006: Hammer Scott M; Saag Michael S; Schechter Mauro; Montaner Julio S G; Schooley Robert T; Jacobsen Donna M; Thompson Melanie A; Carpenter Charles C J; Fischl Margaret A; Gazzard Brian G; Gatell Jose M; Hirsch Martin S; Katzenstein David A; Richman Douglas D; Vella Stefano; Yeni Patrick G; Volberding Paul A;
Treatment for adult HIV infection: 2006 recommendations of the International AIDS Society-USA panel.
JAMA : the journal of the American Medical Association 2006;296(7):827-43.
2006: Pillai Satish K; Pond Sergei L Kosakovsky; Liu Yang; Good Benjamin M; Strain Matthew C; Ellis Ronald J; Letendre Scott; Smith Davey M; Günthard Huldrych F; Grant Igor; Marcotte Thomas D; McCutchan J Allen; Richman Douglas D; Wong Joseph K
Genetic attributes of cerebrospinal fluid-derived HIV-1 env.
Brain : a journal of neurology 2006;129(Pt 7):1872-83.
2006: Pond Sergei L Kosakovsky; Frost Simon D W; Grossman Zehava; Gravenor Michael B; Richman Douglas D; Brown Andrew J Leigh
Adaptation to different human populations by HIV-1 revealed by codon-based analyses.
PLoS computational biology 2006;2(6):e62.
2005: Frost Simon D W; Wrin Terri; Smith Davey M; Kosakovsky Pond Sergei L; Liu Yang; Paxinos Ellen; Chappey Colombe; Galovich Justin; Beauchaine Jeff; Petropoulos Christos J; Little Susan J; Richman Douglas D
Neutralizing antibody responses drive the evolution of human immunodeficiency virus type 1 envelope during recent HIV infection.
Proceedings of the National Academy of Sciences of the United States of America 2005;102(51):18514-9.
2005: Johnson Victoria A; Brun-Vezinet Francoise; Clotet Bonaventura; Conway Brian; Kuritzkes Daniel R; Pillay Deenan; Schapiro Jonathan M; Telenti Amalio; Richman Douglas D
Update of the drug resistance mutations in HIV-1: Fall 2005.
Topics in HIV medicine : a publication of the International AIDS Society, USA 2005;13(4):125-31.
2005: Lehrman Ginger; Hogue Ian B; Palmer Sarah; Jennings Cheryl; Spina Celsa A; Wiegand Ann; Landay Alan L; Coombs Robert W; Richman Douglas D; Mellors John W; Coffin John M; Bosch Ronald J; Margolis David M
Depletion of latent HIV-1 infection in vivo: a proof-of-concept study.
Lancet 2005;366(9485):549-55.
2005: Smith Davey M; Wong Joseph K; Hightower George K; Ignacio Caroline C; Koelsch Kersten K; Petropoulos Christos J; Richman Douglas D; Little Susan J
HIV drug resistance acquired through superinfection.
AIDS (London, England) 2005;19(12):1251-6.
2005: Pillai Satish K; Kosakovsky Pond Sergei L; Woelk Christopher H; Richman Douglas D; Smith Davey M
Codon volatility does not reflect selective pressure on the HIV-1 genome.
Virology 2005;336(2):137-43.
2005: Frost Simon D W; Liu Yang; Pond Sergei L Kosakovsky; Chappey Colombe; Wrin Terri; Petropoulos Christos J; Little Susan J; Richman Douglas D
Characterization of human immunodeficiency virus type 1 (HIV-1) envelope variation and neutralizing antibody responses during transmission of HIV-1 subtype B.
Journal of virology 2005;79(10):6523-7.
2005: Strain Matthew C; Little Susan J; Daar Eric S; Havlir Diane V; Gunthard Huldrych F; Lam Ruby Y; Daly Otto A; Nguyen Juin; Ignacio Caroline C; Spina Celsa A; Richman Douglas D; Wong Joseph K
Effect of treatment, during primary infection, on establishment and clearance of cellular reservoirs of HIV-1.
The Journal of infectious diseases 2005;191(9):1410-8.
2005: Haubrich Richard H; Kemper Carol A; Hellmann Nicholas S; Keiser Philip H; Witt Mallory D; Tilles Jeremiah G; Forthal Donald N; Leedom John; Leibowitz Matthew; McCutchan J Allen; Richman Douglas D;
A randomized, prospective study of phenotype susceptibility testing versus standard of care to manage antiretroviral therapy: CCTG 575.
AIDS (London, England) 2005;19(3):295-302.
2005: Strain M C; Letendre S; Pillai S K; Russell T; Ignacio C C; Günthard H F; Good B; Smith D M; Wolinsky S M; Furtado M; Marquie-Beck J; Durelle J; Grant I; Richman D D; Marcotte T; McCutchan J A; Ellis R J; Wong J K
Genetic composition of human immunodeficiency virus type 1 in cerebrospinal fluid and blood without treatment and during failing antiretroviral therapy.
Journal of virology 2005;79(3):1772-88.
2005: Pillai Satish K; Good Benjamin; Pond Sergei Kosakovsky; Wong Joseph K; Strain Matt C; Richman Douglas D; Smith Davey M
Semen-specific genetic characteristics of human immunodeficiency virus type 1 env.
Journal of virology 2005;79(3):1734-42.
2005: Yang Otto O; Daar Eric S; Jamieson Beth D; Balamurugan Arumugam; Smith Davey M; Pitt Jacqueline A; Petropoulos Christos J; Richman Douglas D; Little Susan J; Brown Andrew J Leigh
Human immunodeficiency virus type 1 clade B superinfection: evidence for differential immune containment of distinct clade B strains.
Journal of virology 2005;79(2):860-8.
2004: Dong Tao; Stewart-Jones Guillaume; Chen Nan; Easterbrook Philippa; Xu Xiaoning; Papagno Laura; Appay Victor; Weekes Michael; Conlon Chris; Spina Celsa; Little Susan; Screaton Gavin; van der Merwe Anton; Richman Douglas D; McMichael Andrew J; Jones E Yvonne; Rowland-Jones Sarah L
HIV-specific cytotoxic T cells from long-term survivors select a unique T cell receptor.
The Journal of experimental medicine 2004;200(12):1547-57.
2004: Woelk Christopher H; Ottones Florence; Plotkin Christine R; Du Pinyi; Royer Christy D; Rought Steffney E; Lozach Jean; Sasik Roman; Kornbluth Richard S; Richman Douglas D; Corbeil Jacques
Interferon gene expression following HIV type 1 infection of monocyte-derived macrophages.
AIDS research and human retroviruses 2004;20(11):1210-22.
2004: Johnson Victoria A; Brun-Vézinet Francoise; Clotet Bonaventura; Conway Brian; D'Aquila Richard T; Demeter Lisa M; Kuritzkes Daniel R; Pillay Deenan; Schapiro Jonathan M; Telenti Amalio; Richman Douglas D
Update of the drug resistance mutations in HIV-1: 2004.
Topics in HIV medicine : a publication of the International AIDS Society, USA 2004;12(4):119-24.
2004: Smith Davey M; Wong Joseph K; Hightower George K; Ignacio Caroline C; Koelsch Kersten K; Daar Eric S; Richman Douglas D; Little Susan J
Incidence of HIV superinfection following primary infection.
JAMA : the journal of the American Medical Association 2004;292(10):1177-8.
2004: Yeni Patrick G; Hammer Scott M; Hirsch Martin S; Saag Michael S; Schechter Mauro; Carpenter Charles C J; Fischl Margaret A; Gatell Jose M; Gazzard Brian G; Jacobsen Donna M; Katzenstein David A; Montaner Julio S G; Richman Douglas D; Schooley Robert T; Thompson Melanie A; Vella Stefano; Volberding Paul A
Treatment for adult HIV infection: 2004 recommendations of the International AIDS Society-USA Panel.
JAMA : the journal of the American Medical Association 2004;292(2):251-65.
2004: Smith Davey M; Kingery Julie D; Wong Joseph K; Ignacio Caroline C; Richman Douglas D; Little Susan J
The prostate as a reservoir for HIV-1.
AIDS (London, England) 2004;18(11):1600-2.
2004: Leigh Brown Andrew J; Frost Simon D W; Good Benjamin; Daar Eric S; Simon Viviana; Markowitz Martin; Collier Ann C; Connick Elizabeth; Conway Brian; Margolick Joseph B; Routy Jean-Pierre; Corbeil Jacques; Hellmann Nicholas S; Richman Douglas D; Little Susan J
Genetic basis of hypersusceptibility to protease inhibitors and low replicative capacity of human immunodeficiency virus type 1 strains in primary infection.
Journal of virology 2004;78(5):2242-6.
2004: Papagno Laura; Spina Celsa A; Marchant Arnaud; Salio Mariolina; Rufer Nathalie; Little Susan; Dong Tao; Chesney Gillian; Waters Anele; Easterbrook Philippa; Dunbar P Rod; Shepherd Dawn; Cerundolo Vincenzo; Emery Vincent; Griffiths Paul; Conlon Christopher; McMichael Andrew J; Richman Douglas D; Rowland-Jones Sarah L; Appay Victor
Immune activation and CD8+ T-cell differentiation towards senescence in HIV-1 infection.
PLoS biology 2004;2(2):E20.
2003: Johnson Victoria A; Brun-Vézinet Françoise; Clotet Bonaventura; Conway Brian; D'Aquila Richard T; Demeter Lisa M; Kuritzkes Daniel R; Pillay Deenan; Schapiro Jonathan M; Telenti Amalio; Richman Douglas D;
Drug resistance mutations in HIV-1.
Topics in HIV medicine : a publication of the International AIDS Society, USA 2003;11(6):215-21.
2003: Gulick Roy M; Meibohm Anne; Havlir Diane; Eron Joseph J; Mosley Audrey; Chodakewitz Jeffrey A; Isaacs Robin; Gonzalez Charles; McMahon Deborah; Richman Douglas D; Robertson Michael; Mellors John W
Six-year follow-up of HIV-1-infected adults in a clinical trial of antiretroviral therapy with indinavir, zidovudine, and lamivudine.
AIDS (London, England) 2003;17(16):2345-9.
2003: Ali Ayub; Pillai Satish; Ng Hwee; Lubong Rachel; Richman Douglas D; Jamieson Beth D; Ding Yan; McElrath M Juliana; Guatelli John C; Yang Otto O
Broadly increased sensitivity to cytotoxic T lymphocytes resulting from Nef epitope escape mutations.
Journal of immunology (Baltimore, Md. : 1950) 2003;171(8):3999-4005.
2003: Haas David W; Wilkinson Grant R; Kuritzkes Daniel R; Richman Douglas D; Nicotera Janet; Mahon Laura F; Sutcliffe Cara; Siminski Sue; Andersen Janet; Coughlin Kristine; Clayton Ellen W; Haines Jonathan; Marshak Ann; Saag Michael; Lawrence Jody; Gustavson Jeffrey; Anne Bennett Jo; Christensen Rolf; Matula Margaret A; Wood Alastair J J;
A multi-investigator/institutional DNA bank for AIDS-related human genetic studies: AACTG Protocol A5128.
HIV clinical trials 2003;4(5):287-300.
2003: Hirsch Martin S; Brun-Vézinet Françoise; Clotet Bonaventura; Conway Brian; Kuritzkes Daniel R; D'Aquila Richard T; Demeter Lisa M; Hammer Scott M; Johnson Victoria A; Loveday Clive; Mellors John W; Richman Douglas D;
Questions to and answers from the International AIDS Society-USA Resistance Testing Guidelines Panel.
Topics in HIV medicine : a publication of the International AIDS Society, USA 2003;11(4):150-4.
2003: Hirsch Martin S; Brun-Vézinet Françoise; Clotet Bonaventura; Conway Brian; Kuritzkes Daniel R; D'Aquila Richard T; Demeter Lisa M; Hammer Scott M; Johnson Victoria A; Loveday Clive; Mellors John W; Jacobsen Donna M; Richman Douglas D
Antiretroviral drug resistance testing in adults infected with human immunodeficiency virus type 1: 2003 recommendations of an International AIDS Society-USA Panel.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2003;37(1):113-28.
2003: Zaunders John J; Moutouh-de Parseval Laure; Kitada Shinichi; Reed John C; Rought Steffney; Genini Davide; Leoni Lorenzo; Kelleher Anthony; Cooper David A; Smith Don E; Grey Pat; Estaquier Jérôme; Little Susan; Richman Douglas D; Corbeil Jacques
Polyclonal proliferation and apoptosis of CCR5+ T lymphocytes during primary human immunodeficiency virus type 1 infection: regulation by interleukin (IL)-2, IL-15, and Bcl-2.
The Journal of infectious diseases 2003;187(11):1735-47.
2003: D'Aquila Richard T; Schapiro Jonathan M; Brun-Vézinet Françoise; Clotet Bonaventura; Conway Brian; Demeter Lisa M; Grant Robert M; Johnson Victoria A; Kuritzkes Daniel R; Loveday Clive; Shafer Robert W; Richman Douglas D
Drug resistance mutations in HIV-1.
Topics in HIV medicine : a publication of the International AIDS Society, USA 2003;11(3):92-6.
2003: Koelsch Kersten K; Smith Davey M; Little Susan J; Ignacio Caroline C; Macaranas Theresa R; Brown Andrew J; Petropoulos Christos J; Richman Douglas D; Wong Joseph K
Clade B HIV-1 superinfection with wild-type virus after primary infection with drug-resistant clade B virus.
AIDS (London, England) 2003;17(7):F11-6.
2003: Strain M C; Günthard H F; Havlir D V; Ignacio C C; Smith D M; Leigh-Brown A J; Macaranas T R; Lam R Y; Daly O A; Fischer M; Opravil M; Levine H; Bacheler L; Spina C A; Richman D D; Wong J K
Heterogeneous clearance rates of long-lived lymphocytes infected with HIV: intrinsic stability predicts lifelong persistence.
Proceedings of the National Academy of Sciences of the United States of America 2003;100(8):4819-24.
2003: Leigh Brown Andrew J; Frost Simon D W; Mathews W Christopher; Dawson Keith; Hellmann Nicholas S; Daar Eric S; Richman Douglas D; Little Susan J
Transmission fitness of drug-resistant human immunodeficiency virus and the prevalence of resistance in the antiretroviral-treated population.
The Journal of infectious diseases 2003;187(4):683-6.
2002: Bennett Kara K; DeGruttola Victor G; Marschner Ian C; Havlir Diane V; Richman Douglas D
Baseline predictors of CD4 T-lymphocyte recovery with combination antiretroviral therapy.
Journal of acquired immune deficiency syndromes (1999) 2002;31(1):20-6.
2002: Little Susan J; Holte Sarah; Routy Jean-Pierre; Daar Eric S; Markowitz Marty; Collier Ann C; Koup Richard A; Mellors John W; Connick Elizabeth; Conway Brian; Kilby Michael; Wang Lei; Whitcomb Jeannette M; Hellmann Nicholas S; Richman Douglas D
Antiretroviral-drug resistance among patients recently infected with HIV.
The New England journal of medicine 2002;347(6):385-94.
2002: Yeni Patrick G; Hammer Scott M; Carpenter Charles C J; Cooper David A; Fischl Margaret A; Gatell Jose M; Gazzard Brian G; Hirsch Martin S; Jacobsen Donna M; Katzenstein David A; Montaner Julio S G; Richman Douglas D; Saag Michael S; Schechter Mauro; Schooley Robert T; Thompson Melanie A; Vella Stefano; Volberding Paul A
Antiretroviral treatment for adult HIV infection in 2002: updated recommendations of the International AIDS Society-USA Panel.
JAMA : the journal of the American Medical Association 2002;288(2):222-35.
2002: Estaquier Jérôme; Lelièvre Jean-Daniel; Petit Frédéric; Brunner Thomas; Moutouh-De Parseval Laure; Richman Douglas D; Ameisen Jean Claude; Corbeil Jacques
Effects of antiretroviral drugs on human immunodeficiency virus type 1-induced CD4(+) T-cell death.
Journal of virology 2002;76(12):5966-73.
2002: Appay Victor; Dunbar P Rod; Callan Margaret; Klenerman Paul; Gillespie Geraldine M A; Papagno Laura; Ogg Graham S; King Abigail; Lechner Franziska; Spina Celsa A; Little Susan; Havlir Diane V; Richman Douglas D; Gruener Norbert; Pape Gerd; Waters Anele; Easterbrook Philippa; Salio Mariolina; Cerundolo Vincenzo; McMichael Andrew J; Rowland-Jones Sarah L
Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections.
Nature medicine 2002;8(4):379-85.
2002: Appay Victor; Papagno Laura; Spina Celsa A; Hansasuta Pokrath; King Abigail; Jones Louise; Ogg Graham S; Little Susan; McMichael Andrew J; Richman Douglas D; Rowland-Jones Sarah L
Dynamics of T cell responses in HIV infection.
Journal of immunology (Baltimore, Md. : 1950) 2002;168(7):3660-6.
2002: Appay Victor; Hansasuta Pokrath; Sutton Julian; Schrier Rachel D; Wong Joseph K; Furtado Manohar; Havlir Diane V; Wolinsky Steven M; McMichael Andrew J; Richman Douglas D; Rowland-Jones Sarah L; Spina Celsa A
Persistent HIV-1-specific cellular responses despite prolonged therapeutic viral suppression.
AIDS (London, England) 2002;16(2):161-70.
2001: Douek D C; Betts M R; Hill B J; Little S J; Lempicki R; Metcalf J A; Casazza J; Yoder C; Adelsberger J W; Stevens R A; Baseler M W; Keiser P; Richman D D; Davey R T; Koup R A
Evidence for increased T cell turnover and decreased thymic output in HIV infection.
Journal of immunology (Baltimore, Md. : 1950) 2001;167(11):6663-8.
2001: Brooun A; Richman D D; Kornbluth R S
HIV-1 preintegration complexes preferentially integrate into longer target DNA molecules in solution as detected by a sensitive, polymerase chain reaction-based integration assay.
The Journal of biological chemistry 2001;276(50):46946-52.
2001: Horner A A; Datta S K; Takabayashi K; Belyakov I M; Hayashi T; Cinman N; Nguyen M D; Van Uden J H; Berzofsky J A; Richman D D; Raz E
Immunostimulatory DNA-based vaccines elicit multifaceted immune responses against HIV at systemic and mucosal sites.
Journal of immunology (Baltimore, Md. : 1950) 2001;167(3):1584-91.
2001: Havlir D V; Gilbert P B; Bennett K; Collier A C; Hirsch M S; Tebas P; Adams E M; Wheat L J; Goodwin D; Schnittman S; Holohan M K; Richman D D;
Effects of treatment intensification with hydroxyurea in HIV-infected patients with virologic suppression.
AIDS (London, England) 2001;15(11):1379-88.
2001: Havlir D V; Bassett R; Levitan D; Gilbert P; Tebas P; Collier A C; Hirsch M S; Ignacio C; Condra J; Günthard H F; Richman D D; Wong J K
Prevalence and predictive value of intermittent viremia with combination hiv therapy.
JAMA : the journal of the American Medical Association 2001;286(2):171-9.
2001: Corbeil J; Sheeter D; Genini D; Rought S; Leoni L; Du P; Ferguson M; Masys D R; Welsh J B; Fink J L; Sasik R; Huang D; Drenkow J; Richman D D; Gingeras T
Temporal gene regulation during HIV-1 infection of human CD4+ T cells.
Genome research 2001;11(7):1198-204.
2001: Frost S D; Günthard H F; Wong J K; Havlir D; Richman D D; Leigh Brown A J
Evidence for positive selection driving the evolution of HIV-1 env under potent antiviral therapy.
Virology 2001;284(2):250-8.
2001: Hammond J L; Koontz D L; Bazmi H Z; Beadle J R; Hostetler S E; Kini G D; Aldern K A; Richman D D; Hostetler K Y; Mellors J W
Alkylglycerol prodrugs of phosphonoformate are potent in vitro inhibitors of nucleoside-resistant human immunodeficiency virus type 1 and select for resistance mutations that suppress zidovudine resistance.
Antimicrobial agents and chemotherapy 2001;45(6):1621-8.
2001: Richman D D; Johnson V A; Mayers D M; Shirasaka T; O'Brien M C; Mitsuya H
In vitro evaluation of experimental agents for anti-HIV activity.
Current protocols in immunology / edited by John E. Coligan ... [et al.] 2001;Chapter 12():Unit 12.9.
2001: Günthard H F; Havlir D V; Fiscus S; Zhang Z Q; Eron J; Mellors J; Gulick R; Frost S D; Brown A J; Schleif W; Valentine F; Jonas L; Meibohm A; Ignacio C C; Isaacs R; Gamagami R; Emini E; Haase A; Richman D D; Wong J K
Residual human immunodeficiency virus (HIV) Type 1 RNA and DNA in lymph nodes and HIV RNA in genital secretions and in cerebrospinal fluid after suppression of viremia for 2 years.
The Journal of infectious diseases 2001;183(9):1318-27.
2001: Daar E S; Little S; Pitt J; Santangelo J; Ho P; Harawa N; Kerndt P; Glorgi J V; Bai J; Gaut P; Richman D D; Mandel S; Nichols S;
Diagnosis of primary HIV-1 infection. Los Angeles County Primary HIV Infection Recruitment Network.
Annals of internal medicine 2001;134(1):25-9.
2001: Genini D; Sheeter D; Rought S; Zaunders J J; Susin S A; Kroemer G; Richman D D; Carson D A; Corbeil J; Leoni L M
HIV induces lymphocyte apoptosis by a p53-initiated, mitochondrial-mediated mechanism.
The FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2001;15(1):5-6.
2000: Zhou X J; Havlir D V; Richman D D; Acosta E P; Hirsch M; Collier A C; Tebas P; Sommadossi J P;
Plasma population pharmacokinetics and penetration into cerebrospinal fluid of indinavir in combination with zidovudine and lamivudine in HIV-1-infected patients.
AIDS (London, England) 2000;14(18):2869-76.
2000: Brown A J; Precious H M; Whitcomb J M; Wong J K; Quigg M; Huang W; Daar E S; D'Aquila R T; Keiser P H; Connick E; Hellmann N S; Petropoulos C J; Richman D D; Little S J
Reduced susceptibility of human immunodeficiency virus type 1 (HIV-1) from patients with primary HIV infection to nonnucleoside reverse transcriptase inhibitors is associated with variation at novel amino acid sites.
Journal of virology 2000;74(22):10269-73.
2000: Gilbert P B; Hanna G J; De Gruttola V; Martinez-Picado J; Kuritzkes D R; Johnson V A; Richman D D; D'Aquila R T
Comparative analysis of HIV type 1 genotypic resistance across antiretroviral trial treatment regimens.
AIDS research and human retroviruses 2000;16(14):1325-36.
2000: Martinez-Picado J; DePasquale M P; Kartsonis N; Hanna G J; Wong J; Finzi D; Rosenberg E; Gunthard H F; Sutton L; Savara A; Petropoulos C J; Hellmann N; Walker B D; Richman D D; Siliciano R; D'Aquila R T
Antiretroviral resistance during successful therapy of HIV type 1 infection.
Proceedings of the National Academy of Sciences of the United States of America 2000;97(20):10948-53.
2000: Tighe H; Takabayashi K; Schwartz D; Marsden R; Beck L; Corbeil J; Richman D D; Eiden J J; Spiegelberg H L; Raz E
Conjugation of protein to immunostimulatory DNA results in a rapid, long-lasting and potent induction of cell-mediated and humoral immunity.
European journal of immunology 2000;30(7):1939-47.
2000: Havlir D V; Tierney C; Friedland G H; Pollard R B; Smeaton L; Sommadossi J P; Fox L; Kessler H; Fife K H; Richman D D
In vivo antagonism with zidovudine plus stavudine combination therapy.
The Journal of infectious diseases 2000;182(1):321-5.
2000: Appay V; Nixon D F; Donahoe S M; Gillespie G M; Dong T; King A; Ogg G S; Spiegel H M; Conlon C; Spina C A; Havlir D V; Richman D D; Waters A; Easterbrook P; McMichael A J; Rowland-Jones S L
HIV-specific CD8(+) T cells produce antiviral cytokines but are impaired in cytolytic function.
The Journal of experimental medicine 2000;192(1):63-75.
2000: Hanna G J; Johnson V A; Kuritzkes D R; Richman D D; Martinez-Picado J; Sutton L; Hazelwood J D; D'Aquila R T
Comparison of sequencing by hybridization and cycle sequencing for genotyping of human immunodeficiency virus type 1 reverse transcriptase.
Journal of clinical microbiology 2000;38(7):2715-21.
2000: Gulick R M; Mellors J W; Havlir D; Eron J J; Meibohm A; Condra J H; Valentine F T; McMahon D; Gonzalez C; Jonas L; Emini E A; Chodakewitz J A; Isaacs R; Richman D D
3-year suppression of HIV viremia with indinavir, zidovudine, and lamivudine.
Annals of internal medicine 2000;133(1):35-9.
2000: Hostetler K Y; Hammond J L; Kini G D; Hostetler S E; Beadle J R; Aldern K A; Chou T C; Richman D D; Mellors J W
In vitro anti-HIV-1 activity of sn-2-substituted 1-O-octadecyl-sn-glycero-3-phosphonoformate analogues and synergy with zidovudine.
Antiviral chemistry & chemotherapy 2000;11(3):213-9.
2000: O'Brien T R; McDermott D H; Ioannidis J P; Carrington M; Murphy P M; Havlir D V; Richman D D
Effect of chemokine receptor gene polymorphisms on the response to potent antiretroviral therapy.
AIDS (London, England) 2000;14(7):821-6.
2000: Hirsch M S; Brun-Vézinet F; D'Aquila R T; Hammer S M; Johnson V A; Kuritzkes D R; Loveday C; Mellors J W; Clotet B; Conway B; Demeter L M; Vella S; Jacobsen D M; Richman D D
Antiretroviral drug resistance testing in adult HIV-1 infection: recommendations of an International AIDS Society-USA Panel.
JAMA : the journal of the American Medical Association 2000;283(18):2417-26.
2000: Hanna G J; Johnson V A; Kuritzkes D R; Richman D D; Brown A J; Savara A V; Hazelwood J D; D'Aquila R T
Patterns of resistance mutations selected by treatment of human immunodeficiency virus type 1 infection with zidovudine, didanosine, and nevirapine.
The Journal of infectious diseases 2000;181(3):904-11.
2000: Günthard H F; Wong J K; Spina C A; Ignacio C; Kwok S; Christopherson C; Hwang J; Haubrich R; Havlir D; Richman D D
Effect of influenza vaccination on viral replication and immune response in persons infected with human immunodeficiency virus receiving potent antiretroviral therapy.
The Journal of infectious diseases 2000;181(2):522-31.
2000: Precious H M; Günthard H F; Wong J K; D'Aquila R T; Johnson V A; Kuritzkes D R; Richman D D; Leigh Brown A J
Multiple sites in HIV-1 reverse transcriptase associated with virological response to combination therapy.
AIDS (London, England) 2000;14(1):31-6.
2000: Carpenter C C; Cooper D A; Fischl M A; Gatell J M; Gazzard B G; Hammer S M; Hirsch M S; Jacobsen D M; Katzenstein D A; Montaner J S; Richman D D; Saag M S; Schechter M; Schooley R T; Thompson M A; Vella S; Yeni P G; Volberding P A
Antiretroviral therapy in adults: updated recommendations of the International AIDS Society-USA Panel.
JAMA : the journal of the American Medical Association 2000;283(3):381-90.
2000: Havlir D V; Hellmann N S; Petropoulos C J; Whitcomb J M; Collier A C; Hirsch M S; Tebas P; Sommadossi J P; Richman D D
Drug susceptibility in HIV infection after viral rebound in patients receiving indinavir-containing regimens.
JAMA : the journal of the American Medical Association 2000;283(2):229-34.
1999: Günthard H F; Frost S D; Leigh-Brown A J; Ignacio C C; Kee K; Perelson A S; Spina C A; Havlir D V; Hezareh M; Looney D J; Richman D D; Wong J K
Evolution of envelope sequences of human immunodeficiency virus type 1 in cellular reservoirs in the setting of potent antiviral therapy.
Journal of virology 1999;73(11):9404-12.
1999: Brown A J; Günthard H F; Wong J K; D'Aquila R T; Johnson V A; Kuritzkes D R; Richman D D
Sequence clusters in human immunodeficiency virus type 1 reverse transcriptase are associated with subsequent virological response to antiretroviral therapy.
The Journal of infectious diseases 1999;180(4):1043-9.
1999: Little S J; Daar E S; D'Aquila R T; Keiser P H; Connick E; Whitcomb J M; Hellmann N S; Petropoulos C J; Sutton L; Pitt J A; Rosenberg E S; Koup R A; Walker B D; Richman D D
Reduced antiretroviral drug susceptibility among patients with primary HIV infection.
JAMA : the journal of the American Medical Association 1999;282(12):1142-9.
1999: Little S J; McLean A R; Spina C A; Richman D D; Havlir D V
Viral dynamics of acute HIV-1 infection.
The Journal of experimental medicine 1999;190(6):841-50.
1999: Craig H M; Pandori M W; Riggs N L; Richman D D; Guatelli J C
Analysis of the SH3-binding region of HIV-1 nef: partial functional defects introduced by mutations in the polyproline helix and the hydrophobic pocket.
Virology 1999;262(1):55-63.
1999: Günthard H F; Leigh-Brown A J; D'Aquila R T; Johnson V A; Kuritzkes D R; Richman D D; Wong J K;
Higher selection pressure from antiretroviral drugs in vivo results in increased evolutionary distance in HIV-1 pol.
Virology 1999;259(1):154-65.
1998: Havlir D V; Marschner I C; Hirsch M S; Collier A C; Tebas P; Bassett R L; Ioannidis J P; Holohan M K; Leavitt R; Boone G; Richman D D
Maintenance antiretroviral therapies in HIV infected patients with undetectable plasma HIV RNA after triple-drug therapy. AIDS Clinical Trials Group Study 343 Team.
The New England journal of medicine 1998;339(18):1261-8.
1998: Riggs N L; Little S J; Richman D D; Guatelli J C
Cell-associated viral RNA expression during acute infection with HIV type 1.
AIDS research and human retroviruses 1998;14(13):1141-9.
1998: Günthard H F; Wong J K; Ignacio C C; Havlir D V; Richman D D
Comparative performance of high-density oligonucleotide sequencing and dideoxynucleotide sequencing of HIV type 1 pol from clinical samples.
AIDS research and human retroviruses 1998;14(10):869-76.
1998: Carpenter C C; Fischl M A; Hammer S M; Hirsch M S; Jacobsen D M; Katzenstein D A; Montaner J S; Richman D D; Saag M S; Schooley R T; Thompson M A; Vella S; Yeni P G; Volberding P A
Antiretroviral therapy for HIV infection in 1998: updated recommendations of the International AIDS Society-USA Panel.
JAMA : the journal of the American Medical Association 1998;280(1):78-86.
1998: Gulick R M; Mellors J W; Havlir D; Eron J J; Gonzalez C; McMahon D; Jonas L; Meibohm A; Holder D; Schleif W A; Condra J H; Emini E A; Isaacs R; Chodakewitz J A; Richman D D
Simultaneous vs sequential initiation of therapy with indinavir, zidovudine, and lamivudine for HIV-1 infection: 100-week follow-up.
JAMA : the journal of the American Medical Association 1998;280(1):35-41.
1998: Hirsch M S; Conway B; D'Aquila R T; Johnson V A; Brun-Vézinet F; Clotet B; Demeter L M; Hammer S M; Jacobsen D M; Kuritzkes D R; Loveday C; Mellors J W; Vella S; Richman D D
Antiretroviral drug resistance testing in adults with HIV infection: implications for clinical management. International AIDS Society--USA Panel.
JAMA : the journal of the American Medical Association 1998;279(24):1984-91.
1998: Kornbluth R S; Kee K; Richman D D
CD40 ligand (CD154) stimulation of macrophages to produce HIV-1-suppressive beta-chemokines.
Proceedings of the National Academy of Sciences of the United States of America 1998;95(9):5205-10.
1998: Günthard H F; Wong J K; Ignacio C C; Guatelli J C; Riggs N L; Havlir D V; Richman D D
Human immunodeficiency virus replication and genotypic resistance in blood and lymph nodes after a year of potent antiretroviral therapy.
Journal of virology 1998;72(3):2422-8.
1998: Beadle J R; Kini G D; Aldern K A; Gardner M F; Wright K N; Richman D D; Hostetler K Y
Alkylthioglycerol prodrugs of foscarnet: synthesis, oral bioavailability and structure-activity studies in human cytomegalovirus-, herpes simplex virus type 1- and human immunodeficiency virus type 1-infected cells.
Antiviral chemistry & chemotherapy 1998;9(1):33-40.
1998: Marschner I C; Collier A C; Coombs R W; D'Aquila R T; DeGruttola V; Fischl M A; Hammer S M; Hughes M D; Johnson V A; Katzenstein D A; Richman D D; Smeaton L M; Spector S A; Saag M S
Use of changes in plasma levels of human immunodeficiency virus type 1 RNA to assess the clinical benefit of antiretroviral therapy.
The Journal of infectious diseases 1998;177(1):40-7.
1997: Wong J K; Hezareh M; Günthard H F; Havlir D V; Ignacio C C; Spina C A; Richman D D
Recovery of replication-competent HIV despite prolonged suppression of plasma viremia.
Science (New York, N.Y.) 1997;278(5341):1291-5.
1997: Wong J K; Günthard H F; Havlir D V; Zhang Z Q; Haase A T; Ignacio C C; Kwok S; Emini E; Richman D D
Reduction of HIV-1 in blood and lymph nodes following potent antiretroviral therapy and the virologic correlates of treatment failure.
Proceedings of the National Academy of Sciences of the United States of America 1997;94(23):12574-9.
1997: Kini G D; Beadle J R; Xie H; Aldern K A; Richman D D; Hostetler K Y
Alkoxy propane prodrugs of foscarnet: effect of alkyl chain length on in vitro antiviral activity in cells infected with HIV-1, HSV-1 and HCMV.
Antiviral research 1997;36(1):43-53.
1997: Gulick R M; Mellors J W; Havlir D; Eron J J; Gonzalez C; McMahon D; Richman D D; Valentine F T; Jonas L; Meibohm A; Emini E A; Chodakewitz J A
Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy.
The New England journal of medicine 1997;337(11):734-9.
1997: Roman M; Martin-Orozco E; Goodman J S; Nguyen M D; Sato Y; Ronaghy A; Kornbluth R S; Richman D D; Carson D A; Raz E
Immunostimulatory DNA sequences function as T helper-1-promoting adjuvants.
Nature medicine 1997;3(8):849-54.
1997: Carpenter C C; Fischl M A; Hammer S M; Hirsch M S; Jacobsen D M; Katzenstein D A; Montaner J S; Richman D D; Saag M S; Schooley R T; Thompson M A; Vella S; Yeni P G; Volberding P A
Antiretroviral therapy for HIV infection in 1997. Updated recommendations of the International AIDS Society-USA panel.
JAMA : the journal of the American Medical Association 1997;277(24):1962-9.
1997: Gervaix A; West D; Leoni L M; Richman D D; Wong-Staal F; Corbeil J
A new reporter cell line to monitor HIV infection and drug susceptibility in vitro.
Proceedings of the National Academy of Sciences of the United States of America 1997;94(9):4653-8.
1997: Brown A J; Richman D D
HIV-1: gambling on the evolution of drug resistance?
Nature medicine 1997;3(3):268-71.
1997: Marschner I C; Mayers D L; Erice A; Smeaton L; Johnson V A; Richman D D; Reichelderfer P; Japour A J
Standardized peripheral blood mononuclear cell culture assay for zidovudine susceptibility testing of clinical human immunodeficiency virus type 1 isolates: effect of reducing the numbers of replicates and concentrations.
Journal of clinical microbiology 1997;35(3):756-8.
1997: Wong J K; Ignacio C C; Torriani F; Havlir D; Fitch N J; Richman D D
In vivo compartmentalization of human immunodeficiency virus: evidence from the examination of pol sequences from autopsy tissues.
Journal of virology 1997;71(3):2059-71.
1996: Havlir D V; Eastman S; Gamst A; Richman D D
Nevirapine-resistant human immunodeficiency virus: kinetics of replication and estimated prevalence in untreated patients.
Journal of virology 1996;70(11):7894-9.
1996: Coombs R W; Welles S L; Hooper C; Reichelderfer P S; D'Aquila R T; Japour A J; Johnson V A; Kuritzkes D R; Richman D D; Kwok S; Todd J; Jackson J B; DeGruttola V; Crumpacker C S; Kahn J
Association of plasma human immunodeficiency virus type 1 RNA level with risk of clinical progression in patients with advanced infection. AIDS Clinical Trials Group (ACTG) 116B/117 Study Team. ACTG Virology Committee Resistance and HIV-1 RNA Working Groups.
The Journal of infectious diseases 1996;174(4):704-12.
1996: Welles S L; Jackson J B; Yen-Lieberman B; Demeter L; Japour A J; Smeaton L M; Johnson V A; Kuritzkes D R; D'Aquila R T; Reichelderfer P A; Richman D D; Reichman R; Fischl M; Dolin R; Coombs R W; Kahn J O; McLaren C; Todd J; Kwok S; Crumpacker C S
Prognostic value of plasma human immunodeficiency virus type 1 (HIV-1) RNA levels in patients with advanced HIV-1 disease and with little or no prior zidovudine therapy. AIDS Clinical Trials Group Protocol 116A/116B/117 Team.
The Journal of infectious diseases 1996;174(4):696-703.
1996: Pandori M W; Fitch N J; Craig H M; Richman D D; Spina C A; Guatelli J C
Producer-cell modification of human immunodeficiency virus type 1: Nef is a virion protein.
Journal of virology 1996;70(7):4283-90.
1996: Carpenter C C; Fischl M A; Hammer S M; Hirsch M S; Jacobsen D M; Katzenstein D A; Montaner J S; Richman D D; Sáag M S; Schooley R T; Thompson M A; Vella S; Yeni P G; Volberding P A
Antiretroviral therapy for HIV infection in 1996. Recommendations of an international panel. International AIDS Society-USA.
JAMA : the journal of the American Medical Association 1996;276(2):146-54.
1996: Hostetler K Y; Kini G D; Beadle J R; Aldern K A; Gardner M F; Border R; Kumar R; Barshak L; Sridhar C N; Wheeler C J; Richman D D
Lipid prodrugs of phosphonoacids: greatly enhanced antiviral activity of 1-O-octadecyl-sn-glycero-3-phosphonoformate in HIV-1, HSV-1 and HCMV-infected cells, in vitro.
Antiviral research 1996;31(1-2):59-67.
1996: Moutouh L; Corbeil J; Richman D D
Recombination leads to the rapid emergence of HIV-1 dually resistant mutants under selective drug pressure.
Proceedings of the National Academy of Sciences of the United States of America 1996;93(12):6106-11.
1996: Havlir D V; Richman D D
Viral dynamics of HIV: implications for drug development and therapeutic strategies.
Annals of internal medicine 1996;124(11):984-94.
1996: Corbeil J; Tremblay M; Richman D D
HIV-induced apoptosis requires the CD4 receptor cytoplasmic tail and is accelerated by interaction of CD4 with p56lck.
The Journal of experimental medicine 1996;183(1):39-48.
1995: Havlir D; McLaughlin M M; Richman D D
A pilot study to evaluate the development of resistance to nevirapine in asymptomatic human immunodeficiency virus-infected patients with CD4 cell counts of > 500/mm3: AIDS Clinical Trials Group Protocol 208.
The Journal of infectious diseases 1995;172(5):1379-83.
1995: Haubrich R H; Flexner C; Lederman M M; Hirsch M; Pettinelli C P; Ginsberg R; Lietman P; Hamzeh F M; Spector S A; Richman D D
A randomized trial of the activity and safety of Ro 24-7429 (Tat antagonist) versus nucleoside for human immunodeficiency virus infection. The AIDS Clinical Trials Group 213 Team.
The Journal of infectious diseases 1995;172(5):1246-52.
1995: Jault F M; Jault J M; Ruchti F; Fortunato E A; Clark C; Corbeil J; Richman D D; Spector D H
Cytomegalovirus infection induces high levels of cyclins, phosphorylated Rb, and p53, leading to cell cycle arrest.
Journal of virology 1995;69(11):6697-704.
1995: Xie H; Voronkov M; Liotta D C; Korba B A; Schinazi R F; Richman D D; Hostetler K Y
Phosphatidyl-2',3'-dideoxy-3'-thiacytidine: synthesis and antiviral activity in hepatitis B-and HIV-1-infected cells.
Antiviral research 1995;28(2):113-20.
1995: Chowers M Y; Pandori M W; Spina C A; Richman D D; Guatelli J C
The growth advantage conferred by HIV-1 nef is determined at the level of viral DNA formation and is independent of CD4 downregulation.
Virology 1995;212(2):451-7.
1995: Spina C A; Guatelli J C; Richman D D
Establishment of a stable, inducible form of human immunodeficiency virus type 1 DNA in quiescent CD4 lymphocytes in vitro.
Journal of virology 1995;69(5):2977-88.
1995: Japour A J; Welles S; D'Aquila R T; Johnson V A; Richman D D; Coombs R W; Reichelderfer P S; Kahn J O; Crumpacker C S; Kuritzkes D R
Prevalence and clinical significance of zidovudine resistance mutations in human immunodeficiency virus isolated from patients after long-term zidovudine treatment. AIDS Clinical Trials Group 116B/117 Study Team and the Virology Committee Resistance Working Group.
The Journal of infectious diseases 1995;171(5):1172-9.
1995: Corbeil J; Evans L A; McQueen P W; Vasak E; Edward P D; Richman D D; Penny R; Cooper D A
Productive in vitro infection of human umbilical vein endothelial cells and three colon carcinoma cell lines with HIV-1.
Immunology and cell biology 1995;73(2):140-5.
1995: D'Aquila R T; Johnson V A; Welles S L; Japour A J; Kuritzkes D R; DeGruttola V; Reichelderfer P S; Coombs R W; Crumpacker C S; Kahn J O; Richman D D
Zidovudine resistance and HIV-1 disease progression during antiretroviral therapy. AIDS Clinical Trials Group Protocol 116B/117 Team and the Virology Committee Resistance Working Group.
Annals of internal medicine 1995;122(6):401-8.
1995: Bozzette S A; Forthal D; Sattler F R; Kemper C; Richman D D; Tilles J G; Leedom J; McCutchan J A
The tolerance for zidovudine plus thrice weekly or daily trimethoprim-sulfamethoxazole with and without leucovorin for primary prophylaxis in advanced HIV disease. California Collaborative Treatment Group.
The American journal of medicine 1995;98(2):177-82.
1995: Meng T C; Fischl M A; Cheeseman S H; Spector S A; Resnick L; Boota A; Petrakis T; Wright B; Richman D D
Combination therapy with recombinant human soluble CD4-immunoglobulin G and zidovudine in patients with HIV infection: a phase I study.
Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association 1995;8(2):152-60.
1994: Little S J; Riggs N L; Chowers M Y; Fitch N J; Richman D D; Spina C A; Guatelli J C
Cell surface CD4 downregulation and resistance to superinfection induced by a defective provirus of HIV-1.
Virology 1994;205(2):578-82.
1994: Meylan P R; Kornbluth R S; Zbinden I; Richman D D
Influence of host cell type and V3 loop of the surface glycoprotein on susceptibility of human immunodeficiency virus type 1 to polyanion compounds.
Antimicrobial agents and chemotherapy 1994;38(12):2910-6.
1994: Hostetler K Y; Richman D D; Sridhar C N; Felgner P L; Felgner J; Ricci J; Gardner M F; Selleseth D W; Ellis M N
Phosphatidylazidothymidine and phosphatidyl-ddC: assessment of uptake in mouse lymphoid tissues and antiviral activities in human immunodeficiency virus-infected cells and in Rauscher leukemia virus-infected mice.
Antimicrobial agents and chemotherapy 1994;38(12):2792-7.
1994: Hostetler K Y; Richman D D; Forssen E A; Selk L; Basava R; Gardner M F; Parker S; Basava C
Phospholipid prodrug inhibitors of the HIV protease. Antiviral activity and pharmacokinetics in rats.
Biochemical pharmacology 1994;48(7):1399-404.
1994: Kornbluth R S; Matsuzaki H; Meylan P R; Richman D D
Interferon interactions with HIV1 in macrophages.
Research in immunology 1994;145(8-9):664-6; discussion 666-8.
1994: Corbeil J; Richman D D; Wrasidlo W; Nicolaou K C; Looney D J
Antiproliferative effects of enediynes on AIDS-derived Kaposi's sarcoma cells.
Cancer research 1994;54(16):4270-3.
1994: Richman D D
Resistance, drug failure, and disease progression.
AIDS research and human retroviruses 1994;10(8):901-5.
1994: Broor S; Kusari A B; Zhang B; Seth P; Richman D D; Carson D A; Wachsman W; Lotz M
Stimulation of HIV replication in mononuclear phagocytes by leukemia inhibitory factor.
Journal of acquired immune deficiency syndromes 1994;7(7):647-54.
1994: Riggs N L; Little S J; Richman D D; Guatelli J C
Biological importance and cooperativity of HIV-1 regulatory gene splice acceptors.
Virology 1994;202(1):264-71.
1994: Corbeil J; Rapaport E; Richman D D; Looney D J
Antiproliferative effect of retinoid compounds on Kaposi's sarcoma cells.
The Journal of clinical investigation 1994;93(5):1981-6.
1994: Chowers M Y; Spina C A; Kwoh T J; Fitch N J; Richman D D; Guatelli J C
Optimal infectivity in vitro of human immunodeficiency virus type 1 requires an intact nef gene.
Journal of virology 1994;68(5):2906-14.
1994: Richman D D; Bozzette S A
The impact of the syncytium-inducing phenotype of human immunodeficiency virus on disease progression.
The Journal of infectious diseases 1994;169(5):968-74.
1994: van Wijk G M; Hostetler K Y; Kroneman E; Richman D D; Sridhar C N; Kumar R; van den Bosch H
Synthesis and antiviral activity of 3'-azido-3'-deoxythymidine triphosphate distearoylglycerol: a novel phospholipid conjugate of the anti-HIV agent AZT.
Chemistry and physics of lipids 1994;70(2):213-22.
1994: Richman D D; Havlir D; Corbeil J; Looney D; Ignacio C; Spector S A; Sullivan J; Cheeseman S; Barringer K; Pauletti D
Nevirapine resistance mutations of human immunodeficiency virus type 1 selected during therapy.
Journal of virology 1994;68(3):1660-6.
1994: Richman D D; Meng T C; Spector S A; Fischl M A; Resnick L; Lai S
Resistance to AZT and ddC during long-term combination therapy in patients with advanced infection with human immunodeficiency virus.
Journal of acquired immune deficiency syndromes 1994;7(2):135-8.
1994: Spina C A; Kwoh T J; Chowers M Y; Guatelli J C; Richman D D
The importance of nef in the induction of human immunodeficiency virus type 1 replication from primary quiescent CD4 lymphocytes.
The Journal of experimental medicine 1994;179(1):115-23.
1993: Bozzette S A; McCutchan J A; Spector S A; Wright B; Richman D D
A cross-sectional comparison of persons with syncytium- and non-syncytium-inducing human immunodeficiency virus.
The Journal of infectious diseases 1993;168(6):1374-9.
1993: Kohsaka H; Taniguchi A; Richman D D; Carson D A
Microtiter format gene quantification by covalent capture of competitive PCR products: application to HIV-1 detection.
Nucleic acids research 1993;21(15):3469-72.
1993: Richman D D
Resistance of clinical isolates of human immunodeficiency virus to antiretroviral agents.
Antimicrobial agents and chemotherapy 1993;37(6):1207-13.
1993: Meylan P R; Spina C A; Richman D D; Kornbluth R S
In vitro differentiation of monocytoid THP-1 cells affects their permissiveness for HIV strains: a model system for studying the cellular basis of HIV differential tropism.
Virology 1993;193(1):256-67.
1993: Skowron G; Bozzette S A; Lim L; Pettinelli C B; Schaumburg H H; Arezzo J; Fischl M A; Powderly W G; Gocke D J; Richman D D; Pottage J C; Antoniskis D; McKinley G F; Hyslop N E; Ray G; Simon G; Reed N; LoFaro M L; Uttamchandani R B; Gelb L D; Sperber S J; Murphy R L; Leedom J M; Grieco M H; Zachary J; Hirsch M S; Spector S A; Bigley J; Soo W; Merigan T C
Alternating and intermittent regimens of zidovudine and dideoxycytidine in patients with AIDS or AIDS-related complex.
Annals of internal medicine 1993;118(5):321-30.
1993: Meylan P R; Guatelli J C; Munis J R; Richman D D; Kornbluth R S
Mechanisms for the inhibition of HIV replication by interferons-alpha, -beta, and -gamma in primary human macrophages.
Virology 1993;193(1):138-48.
1992: Kumar R; Gardner M F; Richman D D; Hostetler K Y
Equal inhibition of HIV replication by stereoisomers of phosphatidyl-azidothymidine. Lack of stereospecificity of lysosomal phospholipase A1.
The Journal of biological chemistry 1992;267(28):20288-92.
1992: Hostetler K Y; Richman D D; Carson D A; Stuhmiller L M; van Wijk G M; van den Bosch H
Greatly enhanced inhibition of human immunodeficiency virus type 1 replication in CEM and HT4-6C cells by 3'-deoxythymidine diphosphate dimyristoylglycerol, a lipid prodrug of 3'-deoxythymidine.
Antimicrobial agents and chemotherapy 1992;36(9):2025-9.
1992: Munis J R; Kornbluth R S; Guatelli J C; Richman D D
Ordered appearance of human immunodeficiency virus type 1 nucleic acids following high multiplicity infection of macrophages.
The Journal of general virology 1992;73 ( Pt 8)():1899-906.
1992: Kahn J O; Lagakos S W; Richman D D; Cross A; Pettinelli C; Liou S H; Brown M; Volberding P A; Crumpacker C S; Beall G
A controlled trial comparing continued zidovudine with didanosine in human immunodeficiency virus infection. The NIAID AIDS Clinical Trials Group.
The New England journal of medicine 1992;327(9):581-7.
1992: Richman D D
HIV drug resistance.
AIDS research and human retroviruses 1992;8(6):1065-71.
1992: Meylan P R; Richman D D; Kornbluth R S
Reduced intracellular growth of mycobacteria in human macrophages cultivated at physiologic oxygen pressure.
The American review of respiratory disease 1992;145(4 Pt 1):947-53.
1992: Meylan P R; Munis J R; Richman D D; Kornbluth R S
Concurrent human immunodeficiency virus and mycobacterial infection of macrophages in vitro does not reveal any reciprocal effect.
The Journal of infectious diseases 1992;165(1):80-6.
1992: Meylan P R; Tam E K; Kornbluth R S; Richman D D
HIV infectivity is not augmented by treatment with trypsin, Factor Xa or human mast-cell tryptase.
AIDS (London, England) 1992;6(1):128-30.
1992: Meng T C; Fischl M A; Boota A M; Spector S A; Bennett D; Bassiakos Y; Lai S H; Wright B; Richman D D
Combination therapy with zidovudine and dideoxycytidine in patients with advanced human immunodeficiency virus infection. A phase I/II study.
Annals of internal medicine 1992;116(1):13-20.
1992: Bozzette S A; Arcia J; Bartok A E; McGlynn L M; McCutchan J A; Richman D D; Spector S A
Impact of Pneumocystis carinii and cytomegalovirus on the course and outcome of atypical pneumonia in advanced human immunodeficiency virus disease.
The Journal of infectious diseases 1992;165(1):93-8.
1992: Day J J; Grant I; Atkinson J H; Brysk L T; McCutchan J A; Hesselink J R; Heaton R K; Weinrich J D; Spector S A; Richman D D
Incidence of AIDS dementia in a two-year follow-up of AIDS and ARC patients on an initial phase II AZT placebo-controlled study: San Diego cohort.
The Journal of neuropsychiatry and clinical neurosciences 1992;4(1):15-20.
1991: Gingeras T R; Prodanovich P; Latimer T; Guatelli J C; Richman D D; Barringer K J
Use of self-sustained sequence replication amplification reaction to analyze and detect mutations in zidovudine-resistant human immunodeficiency virus.
The Journal of infectious diseases 1991;164(6):1066-74.
1991: Richman D D; Guatelli J C; Grimes J; Tsiatis A; Gingeras T
Detection of mutations associated with zidovudine resistance in human immunodeficiency virus by use of the polymerase chain reaction.
The Journal of infectious diseases 1991;164(6):1075-81.
1991: Bozzette S A; Arcia J; Bartok A E; McGlynn L M; McCutchan J A; Richman D D; Spragg R; Spector S A
The impact of concomitant viral pathogens on the course of Pneumocystis carinii pneumonia.
The Journal of protozoology 1991;38(6):183S-184S.
1991: Wu A W; Rubin H R; Mathews W C; Ware J E; Brysk L T; Hardy W D; Bozzette S A; Spector S A; Richman D D
A health status questionnaire using 30 items from the Medical Outcomes Study. Preliminary validation in persons with early HIV infection.
Medical care 1991;29(8):786-98.
1991: Bozzette S A; Larsen R A; Chiu J; Leal M A; Tilles J G; Richman D D; Leedom J M; McCutchan J A
Fluconazole treatment of persistent Cryptococcus neoformans prostatic infection in AIDS.
Annals of internal medicine 1991;115(4):285-6.
1991: Hostetler K Y; Carson D A; Richman D D
Phosphatidylazidothymidine. Mechanism of antiretroviral action in CEM cells.
The Journal of biological chemistry 1991;266(18):11714-7.
1991: Terai C; Kornbluth R S; Pauza C D; Richman D D; Carson D A
Apoptosis as a mechanism of cell death in cultured T lymphoblasts acutely infected with HIV-1.
The Journal of clinical investigation 1991;87(5):1710-5.
1991: Omary M B; Brenner D A; de Grandpre L Y; Roebuck K A; Richman D D; Kagnoff M F
HIV-1 infection and expression in human colonic cells: infection and expression in CD4+ and CD4- cell lines.
AIDS (London, England) 1991;5(3):275-81.
1991: Kagnoff M F; Omary M B; de Grandpre L Y; Roebuck K A; Richman D D; Brenner D A
Expression of human immunodeficiency virus-1 in human colonic cells.
Immunologic research 1991;10(3-4):452-5.
1991: Richman D D
Antiretroviral drug resistance.
AIDS (London, England) 1991;5 Suppl 2():S189-94.
1991: Bozzette S A; Santangelo J; Villasana D; Fraser A; Wright B; Jacobsen C; Hayden E; Schnack J; Spector S A; Richman D D
Peripheral nerve function in persons with asymptomatic or minimally symptomatic HIV disease: absence of zidovudine neurotoxicity.
Journal of acquired immune deficiency syndromes 1991;4(9):851-5.
1990: Guatelli J C; Whitfield K M; Kwoh D Y; Barringer K J; Richman D D; Gingeras T R
Isothermal, in vitro amplification of nucleic acids by a multienzyme reaction modeled after retroviral replication.
Proceedings of the National Academy of Sciences of the United States of America 1990;87(19):7797.
1990: Collier A C; Bozzette S; Coombs R W; Causey D M; Schoenfeld D A; Spector S A; Pettinelli C B; Davies G; Richman D D; Leedom J M
A pilot study of low-dose zidovudine in human immunodeficiency virus infection.
The New England journal of medicine 1990;323(15):1015-21.
1990: Fischl M A; Parker C B; Pettinelli C; Wulfsohn M; Hirsch M S; Collier A C; Antoniskis D; Ho M; Richman D D; Fuchs E
A randomized controlled trial of a reduced daily dose of zidovudine in patients with the acquired immunodeficiency syndrome. The AIDS Clinical Trials Group.
The New England journal of medicine 1990;323(15):1009-14.
1990: Guatelli J C; Gingeras T R; Richman D D
Alternative splice acceptor utilization during human immunodeficiency virus type 1 infection of cultured cells.
Journal of virology 1990;64(9):4093-8.
1990: Gingeras T R; Richman D D; Kwoh D Y; Guatelli J C
Methodologies for in vitro nucleic acid amplification and their applications.
Veterinary microbiology 1990;24(3-4):235-51.
1990: Meylan P R; Richman D D; Kornbluth R S
Characterization and growth in human macrophages of Mycobacterium avium complex strains isolated from the blood of patients with acquired immunodeficiency syndrome.
Infection and immunity 1990;58(8):2564-8.
1990: Kornbluth R S; Munis J R; Oh P S; Meylan P R; Richman D D
Characterization of a macrophage-tropic HIV strain that does not alter macrophage cytokine production yet protects macrophages from superinfection by vesicular stomatitis virus.
AIDS research and human retroviruses 1990;6(8):1023-6.
1990: Richman D D
Susceptibility to nucleoside analogues of zidovudine-resistant isolates of human immunodeficiency virus.
The American journal of medicine 1990;88(5B):8S-10S.
1990: Fischl M A; Richman D D; Hansen N; Collier A C; Carey J T; Para M F; Hardy W D; Dolin R; Powderly W G; Allan J D
The safety and efficacy of zidovudine (AZT) in the treatment of subjects with mildly symptomatic human immunodeficiency virus type 1 (HIV) infection. A double-blind, placebo-controlled trial. The AIDS Clinical Trials Group.
Annals of internal medicine 1990;112(10):727-37.
1990: Hostetler K Y; Stuhmiller L M; Lenting H B; van den Bosch H; Richman D D
Synthesis and antiretroviral activity of phospholipid analogs of azidothymidine and other antiviral nucleosides.
The Journal of biological chemistry 1990;265(11):6112-7.
1990: Guatelli J C; Whitfield K M; Kwoh D Y; Barringer K J; Richman D D; Gingeras T R
Isothermal, in vitro amplification of nucleic acids by a multienzyme reaction modeled after retroviral replication.
Proceedings of the National Academy of Sciences of the United States of America 1990;87(5):1874-8.
1990: Munis J R; Richman D D; Kornbluth R S
Human immunodeficiency virus-1 infection of macrophages in vitro neither induces tumor necrosis factor (TNF)/cachectin gene expression nor alters TNF/cachectin induction by lipopolysaccharide.
The Journal of clinical investigation 1990;85(2):591-6.
1990: Kornbluth R S; Oh P S; Munis J R; Cleveland P H; Richman D D
The role of interferons in the control of HIV replication in macrophages.
Clinical immunology and immunopathology 1990;54(2):200-19.
1990: Wu A W; Mathews W C; Brysk L T; Atkinson J H; Grant I; Abramson I; Kennedy C J; McCutchan J A; Spector S A; Richman D D
Quality of life in a placebo-controlled trial of zidovudine in patients with AIDS and AIDS-related complex.
Journal of acquired immune deficiency syndromes 1990;3(7):683-90.
1990: Richman D D; Grimes J M; Lagakos S W
Effect of stage of disease and drug dose on zidovudine susceptibilities of isolates of human immunodeficiency virus.
Journal of acquired immune deficiency syndromes 1990;3(8):743-6.
1989: Fischl M A; Richman D D; Causey D M; Grieco M H; Bryson Y; Mildvan D; Laskin O L; Groopman J E; Volberding P A; Schooley R T
Prolonged zidovudine therapy in patients with AIDS and advanced AIDS-related complex. AZT Collaborative Working Group.
JAMA : the journal of the American Medical Association 1989;262(17):2405-10.
1989: Larsen R A; Bozzette S; McCutchan J A; Chiu J; Leal M A; Richman D D
Persistent Cryptococcus neoformans infection of the prostate after successful treatment of meningitis. California Collaborative Treatment Group.
Annals of internal medicine 1989;111(2):125-8.
1989: Richman D D
Public access to experimental drug therapy: AIDS raises yet another conflict between freedom of the individual and welfare of the individual and public.
The Journal of infectious diseases 1989;159(3):412-5.
1989: Kornbluth R S; Oh P S; Munis J R; Cleveland P H; Richman D D
Interferons and bacterial lipopolysaccharide protect macrophages from productive infection by human immunodeficiency virus in vitro.
The Journal of experimental medicine 1989;169(3):1137-51.
1988: Atkinson J H; Grant I; Kennedy C J; Richman D D; Spector S A; McCutchan J A
Prevalence of psychiatric disorders among men infected with human immunodeficiency virus. A controlled study.
Archives of general psychiatry 1988;45(9):859-64.
1988: Grant I; Atkinson J H; Hesselink J R; Kennedy C J; Richman D D; Spector S A; McCutchan J A
Human immunodeficiency virus-associated neurobehavioural disorder.
Journal of the Royal College of Physicians of London 1988;22(3):149-57.
1987: Grant I; Atkinson J H; Hesselink J R; Kennedy C J; Richman D D; Spector S A; McCutchan J A
Evidence for early central nervous system involvement in the acquired immunodeficiency syndrome (AIDS) and other human immunodeficiency virus (HIV) infections. Studies with neuropsychologic testing and magnetic resonance imaging.
Annals of internal medicine 1987;107(6):828-36.
1987: Richman D D
Dideoxynucleosides are less inhibitory in vitro against human immunodeficiency virus type 2 (HIV-2) than against HIV-1.
Antimicrobial agents and chemotherapy 1987;31(12):1879-81.
1987: Richman D D; McCutchan J A; Spector S A
Detecting human immunodeficiency virus RNA in peripheral blood mononuclear cells by nucleic acid hybridization.
The Journal of infectious diseases 1987;156(5):823-7.
1987: Richman D D; Kornbluth R S; Carson D A
Failure of dideoxynucleosides to inhibit human immunodeficiency virus replication in cultured human macrophages.
The Journal of experimental medicine 1987;166(4):1144-9.
1987: Richman D D; Fischl M A; Grieco M H; Gottlieb M S; Volberding P A; Laskin O L; Leedom J M; Groopman J E; Mildvan D; Hirsch M S
The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial.
The New England journal of medicine 1987;317(4):192-7.
1987: Fischl M A; Richman D D; Grieco M H; Gottlieb M S; Volberding P A; Laskin O L; Leedom J M; Groopman J E; Mildvan D; Schooley R T
The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial.
The New England journal of medicine 1987;317(4):185-91.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Douglas Richman

Research Profile (preview)

Living Beings

Disorders

Chemicals & Drugs

Physiology

Concepts & Ideas

Procedures

Anatomy

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Douglas Richman (preview)

All Publications